Imagine a world without cancer

Björn L.D.M. Brücher, Gary Lyman, Richard van Hillegersberg, Raphael E. Pollock, Florian Lordick, Han Kwang Yang, Toshikazu Ushijima, Khay Guan Yeoh, Tomas Skricka, Wojciech Polkowski, Grzegorz Wallner, Vic Verwaal, Alfredo Garofalo, Domenico D'Ugo, Franco Roviello, Hans Ulrich Steinau, Timothy J. Wallace, Martin Daumer, Nita Jane Maihle, Thomas J. Reid & 6 others Michel Ducreux, Yuko Kitagawa, Alexander Knuth, Bruno Zilberstein, Scott R. Steele, Ijaz S. Jamall

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Since the " War on Cancer" was declared in 1971, the United States alone has expended some $300 billion on research, with a heavy focus on the role of genomics in anticancer therapy. Voluminous data have been collected and analyzed. However, in hindsight, any achievements made have not been realized in clinical practice in terms of overall survival or quality of life extended. This might be justified because cancer is not one disease but a conglomeration of multiple diseases, with widespread heterogeneity even within a single tumor type.Discussion: Only a few types of cancer have been described that are associated with one major signaling pathway. This enabled the initial successful deployment of targeted therapy for such cancers. However, soon after this targeted approach was initiated, it was subverted as cancer cells learned and reacted to the initial treatments, oftentimes rendering the treatment less effective or even completely ineffective. During the past 30 plus years, the cancer classification used had, as its primary aim, the facilitation of communication and the exchange of information amongst those caring for cancer patients with the end goal of establishing a standardized approach for the diagnosis and treatment of cancers. This approach should be modified based on the recent research to affect a change from a service-based to an outcome-based approach. The vision of achieving long-term control and/or eradicating or curing cancer is far from being realized, but not impossible. In order to meet the challenges in getting there, any newly proposed anticancer strategy must integrate a personalized treatment outcome approach. This concept is predicated on tumor- and patient-associated variables, combined with an individualized response assessment strategy for therapy modification as suggested by the patient's own results. As combined strategies may be outcome-orientated and integrate tumor-, patient- as well as cancer-preventive variables, this approach is likely to result in an optimized anticancer strategy.Summary: Herein, we introduce such an anticancer strategy for all cancer patients, experts, and organizations: Imagine a World without Cancer.

Original languageEnglish (US)
Article number186
JournalBMC Cancer
Volume14
Issue number1
DOIs
StatePublished - Mar 14 2014

Fingerprint

Neoplasms
Therapeutics
Genomics
Research
Communication
Quality of Life
Survival

Keywords

  • Cancer
  • Cancer classification
  • Carcinogenesis
  • Individualized anticancer therapy
  • Multimodal therapy
  • Personalized anticancer therapy

ASJC Scopus subject areas

  • Genetics
  • Oncology
  • Cancer Research

Cite this

Brücher, B. L. D. M., Lyman, G., van Hillegersberg, R., Pollock, R. E., Lordick, F., Yang, H. K., ... Jamall, I. S. (2014). Imagine a world without cancer. BMC Cancer, 14(1), [186]. https://doi.org/10.1186/1471-2407-14-186

Imagine a world without cancer. / Brücher, Björn L.D.M.; Lyman, Gary; van Hillegersberg, Richard; Pollock, Raphael E.; Lordick, Florian; Yang, Han Kwang; Ushijima, Toshikazu; Yeoh, Khay Guan; Skricka, Tomas; Polkowski, Wojciech; Wallner, Grzegorz; Verwaal, Vic; Garofalo, Alfredo; D'Ugo, Domenico; Roviello, Franco; Steinau, Hans Ulrich; Wallace, Timothy J.; Daumer, Martin; Maihle, Nita Jane; Reid, Thomas J.; Ducreux, Michel; Kitagawa, Yuko; Knuth, Alexander; Zilberstein, Bruno; Steele, Scott R.; Jamall, Ijaz S.

In: BMC Cancer, Vol. 14, No. 1, 186, 14.03.2014.

Research output: Contribution to journalArticle

Brücher, BLDM, Lyman, G, van Hillegersberg, R, Pollock, RE, Lordick, F, Yang, HK, Ushijima, T, Yeoh, KG, Skricka, T, Polkowski, W, Wallner, G, Verwaal, V, Garofalo, A, D'Ugo, D, Roviello, F, Steinau, HU, Wallace, TJ, Daumer, M, Maihle, NJ, Reid, TJ, Ducreux, M, Kitagawa, Y, Knuth, A, Zilberstein, B, Steele, SR & Jamall, IS 2014, 'Imagine a world without cancer', BMC Cancer, vol. 14, no. 1, 186. https://doi.org/10.1186/1471-2407-14-186
Brücher BLDM, Lyman G, van Hillegersberg R, Pollock RE, Lordick F, Yang HK et al. Imagine a world without cancer. BMC Cancer. 2014 Mar 14;14(1). 186. https://doi.org/10.1186/1471-2407-14-186
Brücher, Björn L.D.M. ; Lyman, Gary ; van Hillegersberg, Richard ; Pollock, Raphael E. ; Lordick, Florian ; Yang, Han Kwang ; Ushijima, Toshikazu ; Yeoh, Khay Guan ; Skricka, Tomas ; Polkowski, Wojciech ; Wallner, Grzegorz ; Verwaal, Vic ; Garofalo, Alfredo ; D'Ugo, Domenico ; Roviello, Franco ; Steinau, Hans Ulrich ; Wallace, Timothy J. ; Daumer, Martin ; Maihle, Nita Jane ; Reid, Thomas J. ; Ducreux, Michel ; Kitagawa, Yuko ; Knuth, Alexander ; Zilberstein, Bruno ; Steele, Scott R. ; Jamall, Ijaz S. / Imagine a world without cancer. In: BMC Cancer. 2014 ; Vol. 14, No. 1.
@article{985048e90a41468083355d471daedc15,
title = "Imagine a world without cancer",
abstract = "Background: Since the {"} War on Cancer{"} was declared in 1971, the United States alone has expended some $300 billion on research, with a heavy focus on the role of genomics in anticancer therapy. Voluminous data have been collected and analyzed. However, in hindsight, any achievements made have not been realized in clinical practice in terms of overall survival or quality of life extended. This might be justified because cancer is not one disease but a conglomeration of multiple diseases, with widespread heterogeneity even within a single tumor type.Discussion: Only a few types of cancer have been described that are associated with one major signaling pathway. This enabled the initial successful deployment of targeted therapy for such cancers. However, soon after this targeted approach was initiated, it was subverted as cancer cells learned and reacted to the initial treatments, oftentimes rendering the treatment less effective or even completely ineffective. During the past 30 plus years, the cancer classification used had, as its primary aim, the facilitation of communication and the exchange of information amongst those caring for cancer patients with the end goal of establishing a standardized approach for the diagnosis and treatment of cancers. This approach should be modified based on the recent research to affect a change from a service-based to an outcome-based approach. The vision of achieving long-term control and/or eradicating or curing cancer is far from being realized, but not impossible. In order to meet the challenges in getting there, any newly proposed anticancer strategy must integrate a personalized treatment outcome approach. This concept is predicated on tumor- and patient-associated variables, combined with an individualized response assessment strategy for therapy modification as suggested by the patient's own results. As combined strategies may be outcome-orientated and integrate tumor-, patient- as well as cancer-preventive variables, this approach is likely to result in an optimized anticancer strategy.Summary: Herein, we introduce such an anticancer strategy for all cancer patients, experts, and organizations: Imagine a World without Cancer.",
keywords = "Cancer, Cancer classification, Carcinogenesis, Individualized anticancer therapy, Multimodal therapy, Personalized anticancer therapy",
author = "Br{\"u}cher, {Bj{\"o}rn L.D.M.} and Gary Lyman and {van Hillegersberg}, Richard and Pollock, {Raphael E.} and Florian Lordick and Yang, {Han Kwang} and Toshikazu Ushijima and Yeoh, {Khay Guan} and Tomas Skricka and Wojciech Polkowski and Grzegorz Wallner and Vic Verwaal and Alfredo Garofalo and Domenico D'Ugo and Franco Roviello and Steinau, {Hans Ulrich} and Wallace, {Timothy J.} and Martin Daumer and Maihle, {Nita Jane} and Reid, {Thomas J.} and Michel Ducreux and Yuko Kitagawa and Alexander Knuth and Bruno Zilberstein and Steele, {Scott R.} and Jamall, {Ijaz S.}",
year = "2014",
month = "3",
day = "14",
doi = "10.1186/1471-2407-14-186",
language = "English (US)",
volume = "14",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Imagine a world without cancer

AU - Brücher, Björn L.D.M.

AU - Lyman, Gary

AU - van Hillegersberg, Richard

AU - Pollock, Raphael E.

AU - Lordick, Florian

AU - Yang, Han Kwang

AU - Ushijima, Toshikazu

AU - Yeoh, Khay Guan

AU - Skricka, Tomas

AU - Polkowski, Wojciech

AU - Wallner, Grzegorz

AU - Verwaal, Vic

AU - Garofalo, Alfredo

AU - D'Ugo, Domenico

AU - Roviello, Franco

AU - Steinau, Hans Ulrich

AU - Wallace, Timothy J.

AU - Daumer, Martin

AU - Maihle, Nita Jane

AU - Reid, Thomas J.

AU - Ducreux, Michel

AU - Kitagawa, Yuko

AU - Knuth, Alexander

AU - Zilberstein, Bruno

AU - Steele, Scott R.

AU - Jamall, Ijaz S.

PY - 2014/3/14

Y1 - 2014/3/14

N2 - Background: Since the " War on Cancer" was declared in 1971, the United States alone has expended some $300 billion on research, with a heavy focus on the role of genomics in anticancer therapy. Voluminous data have been collected and analyzed. However, in hindsight, any achievements made have not been realized in clinical practice in terms of overall survival or quality of life extended. This might be justified because cancer is not one disease but a conglomeration of multiple diseases, with widespread heterogeneity even within a single tumor type.Discussion: Only a few types of cancer have been described that are associated with one major signaling pathway. This enabled the initial successful deployment of targeted therapy for such cancers. However, soon after this targeted approach was initiated, it was subverted as cancer cells learned and reacted to the initial treatments, oftentimes rendering the treatment less effective or even completely ineffective. During the past 30 plus years, the cancer classification used had, as its primary aim, the facilitation of communication and the exchange of information amongst those caring for cancer patients with the end goal of establishing a standardized approach for the diagnosis and treatment of cancers. This approach should be modified based on the recent research to affect a change from a service-based to an outcome-based approach. The vision of achieving long-term control and/or eradicating or curing cancer is far from being realized, but not impossible. In order to meet the challenges in getting there, any newly proposed anticancer strategy must integrate a personalized treatment outcome approach. This concept is predicated on tumor- and patient-associated variables, combined with an individualized response assessment strategy for therapy modification as suggested by the patient's own results. As combined strategies may be outcome-orientated and integrate tumor-, patient- as well as cancer-preventive variables, this approach is likely to result in an optimized anticancer strategy.Summary: Herein, we introduce such an anticancer strategy for all cancer patients, experts, and organizations: Imagine a World without Cancer.

AB - Background: Since the " War on Cancer" was declared in 1971, the United States alone has expended some $300 billion on research, with a heavy focus on the role of genomics in anticancer therapy. Voluminous data have been collected and analyzed. However, in hindsight, any achievements made have not been realized in clinical practice in terms of overall survival or quality of life extended. This might be justified because cancer is not one disease but a conglomeration of multiple diseases, with widespread heterogeneity even within a single tumor type.Discussion: Only a few types of cancer have been described that are associated with one major signaling pathway. This enabled the initial successful deployment of targeted therapy for such cancers. However, soon after this targeted approach was initiated, it was subverted as cancer cells learned and reacted to the initial treatments, oftentimes rendering the treatment less effective or even completely ineffective. During the past 30 plus years, the cancer classification used had, as its primary aim, the facilitation of communication and the exchange of information amongst those caring for cancer patients with the end goal of establishing a standardized approach for the diagnosis and treatment of cancers. This approach should be modified based on the recent research to affect a change from a service-based to an outcome-based approach. The vision of achieving long-term control and/or eradicating or curing cancer is far from being realized, but not impossible. In order to meet the challenges in getting there, any newly proposed anticancer strategy must integrate a personalized treatment outcome approach. This concept is predicated on tumor- and patient-associated variables, combined with an individualized response assessment strategy for therapy modification as suggested by the patient's own results. As combined strategies may be outcome-orientated and integrate tumor-, patient- as well as cancer-preventive variables, this approach is likely to result in an optimized anticancer strategy.Summary: Herein, we introduce such an anticancer strategy for all cancer patients, experts, and organizations: Imagine a World without Cancer.

KW - Cancer

KW - Cancer classification

KW - Carcinogenesis

KW - Individualized anticancer therapy

KW - Multimodal therapy

KW - Personalized anticancer therapy

UR - http://www.scopus.com/inward/record.url?scp=84899112171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899112171&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-14-186

DO - 10.1186/1471-2407-14-186

M3 - Article

VL - 14

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 186

ER -